参考文献/References:
[1] Schnabel RB,Yin X,Gona P,et al. Fifty-year trends in atrial fibrillation prevalence,incidence,risk factors,and mortality in the community[J].Lancet,2015,386(9989):154-162.
[2] January CT,Wann LS,Calkins H,et al. 2019 AHA/ACC/HRS Focused Update of the 2014 AHA/ACC/HRS Guideline for the Management of Patients With Atrial Fibrillation[J]. Circulation,2019,140(2):e125-e151.
[3] Chang SS,Dong JZ,Ma CS,et al. Current status and time trends of oral anticoagulation use among chinese patients with nonvalvular atrial fibrillation: the chinese atrial fibrillation registry study[J]. Stroke,2016,47(7):1803-1810.
[4] Aberg H. Atrial Fibrillation: I. A study of atrial thrombosis and systemic embolism in a necropsy material[J].Acta Med Scand,1969,185(1-6):373-379.
[5] Blackshear JL,Odell JA. Appendage obliteration to reduce stroke in cardiac surgical patients with atrial fibrillation[J].Ann Thorac Surg,1996,61(2):755-759.
[6] 熊婧,陈维.经皮左心耳封堵术研究回顾与展望[J].中国介入心脏病学杂志,2018,26(10):589-592.
[7] Reddy VY,Sievert H,Halperin J,et al. Percutaneous left atrial appendage closure vs warfarin for atrial fibrillation: a randomized clinical trial[J].JAMA,2014,312(19):1988-1998.
[8] Reddy VY,Holmes D,Doshi SK,et al. Safety of percutaneous left atrial appendage closure: results from the Watchman Left Atrial Appendage System for Embolic Protection in Patients with AF (PROTECT AF) clinical trial and the Continued Access Registry[J]. Circulation,2011,123(4):417-424.
[9] Reddy VY,MoBius-Winkler S,Miller M A,et al. Left atrial appendage closure with the watchman device in patients with a contraindication for oral anticoagulation[J]. J Am Coll Cardiol,2013,61(25):2551-2556.
[10] Holmes DJ,Kar S,Price MJ,et al. Prospective randomized evaluation of the Watchman Left Atrial Appendage Closure device in patients with atrial fibrillation versus long-term warfarin therapy: the PREVAIL trial[J]. J Am Coll Cardiol,2014,64(1):1-12.
[11] Boersma LV,Ince H,Kische S,et al.Evaluating real-world clinical outcomes in atrial fibrillation patients receiving the WATCHMAN left atrial appendage closure technology[J].Circ Arrhythm Electrophysiol,2019,12(4):e006841.
[12] Wilber DJ. Neurohormonal regulation and the left atrial appendage[J]. J Am Coll Cardiol,2018,71(2):145-147.
[13] Kappagoda CT,Linden RJ,Saunders DA . The effect on heart rate of distending the atrial appendages in the dog[J]. J Physiol,1972,225(3):705-719.
[14] Agmon Y,Khandheria BK,Meissner I,et al. Left atrial appendage flow velocities in subjects with normal left ventricular function[J]. Am J Cardiol,2000,86(7):769-773.
[15] Chapeau C,Gutkowska J,Schiller PW,et al. Localization of immunoreactive synthetic atrial natriuretic factor (ANF) in the heart of various animal species[J]. J Histochem Cytochem,1985,33(6):541-550.
[16] Inoue S,Murakami Y,Sano K,et al.Atrium as a source of brain natriuretic polypeptide in patients with atrial fibrillation[J].J Card Fail,2000,6(2):92-96.
[17] 亢扬. 心力衰竭患者血浆B型利钠肽/氨基末端利钠肽原水平正常的研究进展[J]. 心血管病学进展,2018,39(4):622-626.
[18] Pandey KN. Guanylyl cyclase/atrial natriuretic peptide receptor-A: role in the pathophysiology of cardiovascular regulation[J]. Can J Physiol Pharmacol,2011,89(8):557-573.
[19] Haanwinckel MA, Elias LK, Favaretto AL,et al. Oxytocin mediates atrial natriuretic peptide release and natriuresis after volume expansion in the rat[J].Proc Natl Acad Sci U S A,1995,92(17):7902-7906.
[20] Hopkins WE, Chen Z, Fukagawa NK,et al. Fukagawa. Increased atrial and brain natriuretic peptides in adults with cyanotic congenital heart disease; enhanced understanding of the relationship between hypoxia and natriuetic peptide secretion[J]. Circulation,2004,109(23):2872-2877.
[21] Stewart JM,Dean R,Brown M,et al. Bilateral atrial appendectomy abolishes increased plasma atrial natriuretic peptide release and blunts sodium and water excretion during volume loading in conscious dogs[J]. Circ Res,1992,70(4):724-732.
[22] Benjamin BA,Metzler CH,Peterson TV. Chronic atrial appendectomy alters sodium excretion in conscious monkeys[J].Am J Physiol,1988,254(4):R699-R705.
[23] Yoshihara F,Nishikimi T,Kosakai Y,et al. Atrial natriuretic peptide secretion and body fluid balance after bilateral atrial appendectomy by the maze procedure[J].J Thorac Cardiovasc Surg,1998,116(2):213-219.
[24] Majunke N,Sandri M,Adams V,et al. Atrial and brain natriuretic peptide secretion after percutaneous closure of the left atrial appendage with the watchman device[J]. J Invasive Cardiol,2015,27(10):448-452.
[25] Lakkireddy D,Turagam M,Afzal MR,et al. Left atrial appendage closure and systemic homeostasis[J]. J Am Coll Cardiol,2018,71(2):135-144.
[26] Luani B,Rauwolf T,Groscheck T,et al. Serial assessment of natriuretic peptides in patients undergoing interventional closure of the left atrial appendage[J]. Heart Lung Circ,2018,27(7):828-834.
[27] Cruz-Gonzalez I,Palazuelos Molinero J,Valenzuela M,et al. Brain natriuretic peptide levels variation after left atrial appendage occlusion[J].Catheter Cardiovasc Interv,2016,87(1):E39-E43.
[28] Behnes M,Sartorius B,Wenke A,et al. Percutaneous closure of left atrial appendage affects mid-term release of MR-proANP[J].Sci Rep,2017,7(1):9028.
[29] 高虹,杨波,叶距亨,等.左心耳封堵术对非瓣膜性房颤患者心功能和神经内分泌功能的影响[J].中华生物医学工程杂志,2017,023(1):37-40.
[30] de Bold AJ,Bruneau BG,Kuroski de Bold ML.Mechanical and neuroendocrine regulation of the endocrine heart[J].Cardiovasc Res,1996,31(1):7-18.
[31] Bergmann MW, Landmesser U. Left atrial appendage closure for stroke prevention in non-valvular atrial fibrillation: rationale, devices in clinical development and insights into implantation techniques[J]. EuroIntervention,2014,10(4):497-504.
[32] Maybrook R,Pillarisetti J,Yarlagadda V,et al.Electrolyte and hemodynamic changes following percutaneous left atrial appendage ligation with the LARIAT device[J].J Interv Card Electrophysiol,2015,43(3):245-251.
[33] Sattler K,Behnes M,Barth C,et al. Occlusion of left atrial appendage affects metabolomic profile: focus on glycolysis,tricarboxylic acid and urea metabolism[J]. Metabolomics,2017,13(11):127.
[34] Yücel G,Behnes M,Barth C,et al.Percutaneous closure of left atrial appendage significantly affects lipidome metabolism[J]. Sci Rep,2018,8(1):5894.
相似文献/References:
[1]安硕研,郑金刚.左心耳封堵术预防心源性卒中的进展[J].心血管病学进展,2019,(6):869.[doi:10.16806/j.cnki.issn.1004-3934.2019.06.008]
AN Shuoyan,ZHENG Jingang.Left Atrial Appendage Closure for Prevention of Cardiogenic Stroke[J].Advances in Cardiovascular Diseases,2019,(12):869.[doi:10.16806/j.cnki.issn.1004-3934.2019.06.008]
[2]朱世杰,郑慕晗,张建武,等.心脏CT在左心耳封堵术中的应用价值[J].心血管病学进展,2020,(1):11.[doi:10.16806/j.cnki.issn.1004-3934.2020.01.004]
ZHU Shijie,ZHENG Muhan,ZHANG Jianwu,et al.Application of Cardiac CT in Left Atrial Appendage Closure[J].Advances in Cardiovascular Diseases,2020,(12):11.[doi:10.16806/j.cnki.issn.1004-3934.2020.01.004]
[3]李亚会 黄从新.左心耳封堵术常见并发症及其防治[J].心血管病学进展,2021,(5):408.[doi:10.16806/j.cnki.issn.1004-3934.2021.05.006]
LI YahuiHUANG Congxin.Common Complications of Left Atrial Appendage Occlusion and Its Prevention and Treatment[J].Advances in Cardiovascular Diseases,2021,(12):408.[doi:10.16806/j.cnki.issn.1004-3934.2021.05.006]
[4]吴阳 杨桂荣 张波 陈各才.双源CT在左心耳封堵术前评估及指导选择WatchmanTM封堵器型号的应用[J].心血管病学进展,2021,(4):374.[doi:10.16806/j.cnki.issn.1004-3934.2020.04.020]
WU Yang,YANG Guirong,ZHANG Bo,et al.The Application of Dual Source CT in Preoperative Evaluation of Left Atrial Appendage Occlusion and Size Selection of Watchman TM Occluder.com[J].Advances in Cardiovascular Diseases,2021,(12):374.[doi:10.16806/j.cnki.issn.1004-3934.2020.04.020]
[5]柏懿璇 崔凯军.左心耳封堵术后装置相关血栓[J].心血管病学进展,2022,(5):407.[doi:10.16806/j.cnki.issn.1004-3934.2022.05.006]
BAI Yixuan,CUI Kaijun.Device-Related Thrombus After Left Atrial Appendage Occlusion[J].Advances in Cardiovascular Diseases,2022,(12):407.[doi:10.16806/j.cnki.issn.1004-3934.2022.05.006]
[6]王璐 李耀东.TAVR合并心房颤动抗凝策略的研究进展[J].心血管病学进展,2022,(8):695.[doi:10.16806/j.cnki.issn.1004-3934.2022.08.007]
WANG Lu,LI Yaodong.Anticoagulation Strategy in Patients After TAVR Complicated with Atrial Fibrillation[J].Advances in Cardiovascular Diseases,2022,(12):695.[doi:10.16806/j.cnki.issn.1004-3934.2022.08.007]
[7]魏志梁 孙雨可 尹月娇 孙守刚.心房颤动合并慢性肾脏病患者的左心耳封堵治疗研究进展[J].心血管病学进展,2022,(9):783.[doi:10.16806/j.cnki.issn.1004-3934.2022.09.005]
WEI Zhiliang,SUN Yuke,YIN Yuejiao,et al.Left Atrial Appendage Closure in Patients with Atrial Fibrillation Complicated with Chronic Kidney Disease[J].Advances in Cardiovascular Diseases,2022,(12):783.[doi:10.16806/j.cnki.issn.1004-3934.2022.09.005]
[8]加依娜·加尔肯 汤宝鹏 周贤惠 李耀东 芦颜美.非瓣膜性心房颤动患者“一站式”手术策略的有效性和安全性:单中心经验[J].心血管病学进展,2022,(12):1141.[doi:10.16806/j.cnki.issn.1004-3934.2022.12.019]
Jiayina Jiaerken,TANG Baopeng,ZHOU Xianhui,et al.Effectiveness and Safety of "One-Step" Procedure in Patients with Non-Valvular Atrial Fibrillation:A Single Center Experience?/html>[J].Advances in Cardiovascular Diseases,2022,(12):1141.[doi:10.16806/j.cnki.issn.1004-3934.2022.12.019]
[9]许溪麟 李小明.艾多沙班在心血管疾病应用的研究进展[J].心血管病学进展,2024,(5):451.[doi:10.16806/j.cnki.issn.1004-3934.2024.05.016]
XU Xilin,LI Xiaoming.Application of Edoxaban in Cardiovascular Disease[J].Advances in Cardiovascular Diseases,2024,(12):451.[doi:10.16806/j.cnki.issn.1004-3934.2024.05.016]
[10]彭金华,王平,胡婧,等.左心耳封堵术对非瓣膜性心房颤动患者心脏利尿钠肽分泌功能的影响[J].心血管病学进展,2019,(6):873.[doi:10.16806/j.cnki.issn.1004-3934.2019.06.009]
PENG Jinhua,WANG PingHU Jing,YANG Jingqi,et al.Effect of Left Atrial Appendage Closure on Cardiac Natriuretic Peptide Secretion in Patients with Nonvalvular Atrial Fibrillation[J].Advances in Cardiovascular Diseases,2019,(12):873.[doi:10.16806/j.cnki.issn.1004-3934.2019.06.009]
[11]邓蕊 李洪仕 蔡衡.左心耳封堵术对非瓣膜性心房颤动合并冠状动脉性心脏病的价值[J].心血管病学进展,2022,(11):966.[doi:10.16806/j.cnki.issn.1004-3934.2022.11.002]
DENG Rui,LI Hongshi,CAI Heng.Value of Left Atrial Appendage Closure on Non-Valvular Atrial Fibrillation with Coronary Heart Disease[J].Advances in Cardiovascular Diseases,2022,(12):966.[doi:10.16806/j.cnki.issn.1004-3934.2022.11.002]
[12]秦可隽?姜述斌.左心耳封堵术对非瓣膜性心房颤动患者左心功能影响的研究进展[J].心血管病学进展,2024,(5):425.[doi:10.16806/j.cnki.issn.1004-3934.2024.05.010]
QIN KejuanJIANG Shubin.Effects of Left Atrial Appendage Closure on Left Heart Function in Patients with Nonvalvular Atrial Fibrillation[J].Advances in Cardiovascular Diseases,2024,(12):425.[doi:10.16806/j.cnki.issn.1004-3934.2024.05.010]